Insights
The latest knowledge, ideas
and experiences driving our work
Filter by:
-
Suralink User Group update – 24 February
1min read
A summary of the Suralink User Group held on Wednesday 24 February.
-
-
Brokers need a crystal ball
1min read
It’s easier to look back on tax changes than know what’s on the horizon. But our Head of Tax, Chris Riley, makes some predictions.
-
Resilience versus wind-down in 2021
1min read
Many insurance firms have coped well with the effects of the pandemic. But, as the fallout continues, what should their focus be this year?
-
Tax issues: stay on top
1min read
What should brokers and MGAs be looking out for from the tax world? Here’s our digest.
-
Dear CEO: reading between the lines
1min read
Insurance intermediaries may have forgotten, or be unclear, about the FCA’s letter issued in the autumn. Here’s a reminder.
-
Deal alert: Spinnaker Opportunities plc
1min read
We are delighted to have supported Spinnaker Opportunities plc renamed Kanabo Group plc on their admission to the Main Market of the London Stock Exchange following its reverse takeover (RTO) of Kanabo Research Ltd.
-
Charity guide: A healthy appetite
1min read
A risk appetite statement is an essential tool, ensuring that the charity is sustainable, but is also making an impact and delivering on its aims
-
Effective internal audit in the financial services sector
1min read
In January 2021, a new version of the Chartered Institute of Internal Auditors Internal Audit Financial Services Code of Practice: Guidance on effective internal audit in the financial services sector (‘the Code’) was published.
-
New year, new FS Code
1min read
As we start the new year, Heads of Internal Audit may be wondering what lies ahead in 2021 for their internal audit functions.
-
On demand webinar: Preparing your business for the new IR35 rules
1min read
Watch our on demand webinar on preparing your business for the new IR35 rules – contractor vs employee.
-
Deal alert: MGC Pharmaceuticals Ltd
1min read
We are delighted to have supported MGC Pharmaceuticals Ltd on their admission to the main market of the London Stock Exchange.
